MedPath

Hemodialysis-Induced Renal Perfusion Decline: Unraveling the Pathophysiological Mechanisms Linking Intradialytic Circulatory Stress to Residual Renal Function Loss

Active, not recruiting
Conditions
End-Stage Renal Disease Requiring Haemodialysis
Registration Number
NCT07003828
Lead Sponsor
Yuanjun Yang
Brief Summary

Residual renal function (RRF) plays a critical role in quality of life and survival in hemodialysis (HD) patients but characteristically declines after the initiation of HD. Owing to incomplete understanding of the pathophysiology underlying RRF decline, protective strategies remain limited. The aim of this study was to characterize the changes in renal perfusion in incident HD patients with preserved RRF during dialysis sessions and to provide new strategies for RRF preservation.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • (1) adult patients with end-stage renal disease (ESRD) within 3 months of commencing HD; (2) preserved RRF defined as urinary output >500 mL/24 h or eGFR ≥3 mL/min/1.73 m²
Exclusion Criteria
  • (1) known allergy to sulfur hexafluoride microbubbles (SonoVue®) microbubbles; (2) vascular access dysfunction; (3) combined peritoneal dialysis; (4)severe cardiopulmonary disease; (5) active infection or malignancy; (6) communicable diseases; (7) pregnancy or breastfeeding; (8) participation in other clinical trials.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Renal perfusionat three time points during the HD session: pre-dialysis baseline, intradialytic phase (3 hours post-initiation)

Renal perfusion was quantified using the CEUS-assessed perfusion index (PI). The primary outcome measure was the PI.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

the First Medical Center of Chinese PLA General Hospital

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath